Brian Stidsen Vandahl

Director, Protein Structure and Interaction, Biopharm. Research Unit at Novo Nordisk A/S

Brian holds an MSc in Molecular Biology and has a PhD from Health, AU.

Brian has previously worked as a research scientist at Statens Serum Institut and Novo Nordisk A/S. 

Brian has a great deal of experience in the field of biotechnological research with a focus on development of protein-based pharmaceuticals.

He currently works as Director at Novo Nordisk A/S, where he is heading a protein chemical research department employing around 24 people including technicians and academics with a PhD in a protein related field. The department is part of the Biopharmaceuticals Research Unit aiming at developing novel therapeutics within haemophilia, growth disorders, and autoimmune inflammatory diseases.